Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,601 | 4,022 | 9,541 | 4,807 | 6,170 |
| Receivables | 9,357 | 10,335 | 10,958 | 15,797 | 13,155 |
| Other current assets | 3,245 | 4,680 | 2,707 | 2,881 | 2,544 |
| TOTAL | $14,203 | $19,037 | $23,206 | $23,485 | $21,869 |
| Non-Current Assets | |||||
| PPE Net | 4,742 | 4,876 | 5,550 | 6,009 | 4,724 |
| Investments And Advances | 243 | 244 | 246 | 247 | 249 |
| Intangibles | 21,533 | 21,632 | 22,470 | 22,514 | 13,429 |
| Other Non-Current Assets | 650 | 655 | 749 | 1,715 | 678 |
| TOTAL | $27,168 | $27,407 | $29,015 | $30,485 | $19,080 |
| Total Assets | $41,371 | $46,444 | $52,221 | $53,970 | $40,949 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,438 | 9,510 | 10,137 | 2,000 | 2,000 |
| Accounts payable and accrued liabilities | 9,778 | 8,921 | 8,715 | 9,314 | 6,716 |
| Other current liabilities | N/A | 221 | N/A | N/A | N/A |
| TOTAL | $21,542 | $20,722 | $19,640 | $11,694 | $9,111 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 4,936 | 4,838 |
| Deferred Revenues | 2,004 | 1,751 | 516 | 109 | 133 |
| Other Non-Current Liabilities | 1,134 | 3,711 | 4,403 | 4,167 | 7,043 |
| TOTAL | $2,549 | $5,668 | $5,816 | $11,140 | $13,213 |
| Total Liabilities | $24,091 | $26,390 | $25,456 | $22,834 | $22,324 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 185 | 185 | 185 | 162 | 132 |
| Common Shares | 3 | 3 | 3 | 2 | 2 |
| Retained earnings | -145,432 | -141,799 | -134,834 | -126,933 | -126,300 |
| Other shareholders' equity | 134 | 49 | 69 | -1 | 0 |
| TOTAL | $17,280 | $20,054 | $26,765 | $31,136 | $18,625 |
| Total Liabilities And Equity | $41,371 | $46,444 | $52,221 | $53,970 | $40,949 |